The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. (Q34194117)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Nicoletta Biglia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Furio Maggiorotto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Piero Sismondi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Eleftherios P. Diamandis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

George M Yousef

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Terukazu Nakamura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Mohamed Abd Ellatif

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Riccardo Ponzone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Riccardo Roagna

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

149-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12725415%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1022931403825

3 November 2019

exact match

0 references

cites work

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

Breast cancer: cause and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

A novel protease homolog differentially expressed in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Sequence analysis and expression of human neuropsin cDNA and gene.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

The new human kallikrein gene family: implications in carcinogenesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Human tissue kallikrein gene family: a rich source of novel disease biomarkers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Prostate-specific Antigen: Its Usefulness in Clinical Medicine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Role of the androgen receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Role of hormones in mammary cancer initiation and progression

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Antiangiogenic activity of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Prognostic factors: rationale and methods of analysis and integration

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021

Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022931403825

7 January 2021